Key references: Prevalence and risk of psychiatric disorders in people with developmental disability
Burke C, Hastings R, Lavis P, on behalf of the Children and Young People’s Mental Health Coalition . Overshadowed--The mental health needs of children and young people with learning disabilities. London: Children and Young People’s Mental Health Coalition; 2019. https://cypmhc.org.uk/publications/overshadowed/
Dinkler L, Lundstrom S, Gajwani R, Lichtenstein P, Gillberg C, Minnis H. Maltreatment-associated neurodevelopmental disorders: a co-twin control analysis. J Child Psychol Psychiatry 2017;58(6):691–701. https://www.ncbi.nlm.nih.gov/pubmed/28094432
Hassiotis A, Brown E, Harris J, Helm D, Munir K, Salvador-Carulla L, et al. Association of borderline intellectual functioning and adverse childhood experience with adult psychiatric morbidity. Findings from a British birth cohort. BMC Psychiatry 2019;19(1):387. https://www.ncbi.nlm.nih.gov/pubmed/31805899
Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, et al. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health 2017;2(8):e356–e66. https://www.ncbi.nlm.nih.gov/pubmed/29253477
Medeiros K, Rojahn J, Moore LL, van Ingen DJ. Functional properties of behaviour problems depending on level of intellectual disability. J Intellect Disabil Res 2014;58(2):151–61. https://www.ncbi.nlm.nih.gov/pubmed/23464786
Munir KM. The co-occurrence of mental disorders in children and adolescents with intellectual disability/intellectual developmental disorder. Curr Opin Psychiatry 2016;29(2):95–102. https://www.ncbi.nlm.nih.gov/pubmed/26779862
Pearson DA, Lane DM, Santos CW, Casat CD, Jerger SW, Loveland KA, et al. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response. J Am Acad Child Adolesc Psychiatry 2004;43(6):686–98. https://www.ncbi.nlm.nih.gov/pubmed/15167085